COG — Cambridge Cognition Holdings Share News
0.000.00%
Last trade - 00:00- £15.10m
- £14.02m
- £13.52m
- 15
- 20
- 65
- 21
REG - Cambridge Cognition - Notice of Results and Investor Presentation
AnnouncementREG - Cambridge Cognition - Contract Win
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Contract Win
AnnouncementREG - Cambridge Cognition - Block Listing Return
AnnouncementRCS - Cambridge Cognition - CANTAB® used for major global brain health study
AnnouncementRCS - Cambridge Cognition - Cambridge Cognition submits FDA Letter of Intent
AnnouncementREG - Cambridge Cognition - Board Appointment
AnnouncementREG - Cambridge Cognition - Launch of in-house rater training service
AnnouncementREG - Cambridge Cognition - Expanded partnership with Actinogen
AnnouncementRCS - Cambridge Cognition - CANTAB® success in Bristol Myers Squib research
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Trading Update
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Monument Therapeutics secures £1m investment
AnnouncementRCS - Cambridge Cognition - New data demonstrates effectiveness of AQUA
AnnouncementREG - Cambridge Cognition - Directorate Change
Announcement